Navigation Links
Haemonetics Appoints Executive Leadership of European Operations

Mikael Gordon Hired as President of Haemonetics Europe

BRAINTREE, Mass., Nov. 8 /PRNewswire-FirstCall/ -- Haemonetics Corporation is pleased to announce that Mikael Gordon will join the company effective November 12, 2007 as President of Haemonetics Europe. Mr. Gordon will have responsibility for European operations, including sales and marketing, services, finance and human resources and will be based at the company's European Headquarters in Signy, Switzerland. He will also join Haemonetics' global Operating Committee.

Mr. Gordon has more than 20 years of management experience across broad functions and disciplines, with particular focus in life sciences and healthcare. He was employed in executive management, sales, marketing, strategic planning, and information technology positions during his ten year career at Amersham Pharmacia and later GE Healthcare when it acquired Amersham. Most recently, Mr. Gordon was Regional Executive Manager, North and West Europe for GE Healthcare Clinical Systems, which provides hospitals with anesthesia, ventilation, and diagnostic cardiology systems and services. Prior to GE Healthcare, he was employed in executive positions with Lagerkvist & Partners AB, BNL Information AB, Industrifinans Service AB, and McCormack and Dodge AB.

Brian Concannon, Haemonetics' Chief Operating Officer, said, "I am very excited to have someone of Mikael's capability and background joining our team. Mikael has tremendous experience in managing diverse, multi-national businesses and a consistent track record of building and leading high performing teams. I am confident that he will continue to drive strong results and accelerate growth as we complete our business transformation initiatives in Europe."

Mr. Gordon, age 52, is a graduate of Stockholm School of Economics and holds a bachelor of science degree in international economics and business administration.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at .


Julie Fallon

Tel. (781) 356-9517

Alternate Tel. (617) 320-2401

SOURCE Haemonetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Haemonetics Webcast Presentation
2. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
3. WorldHeart Appoints David Pellone Chief Financial Officer
4. Novo Nordisk Appoints New Leader of North American Business
5. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
6. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
7. Resonant Medical Appoints New Vice President of Global Sales
8. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
9. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
10. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
11. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
Post Your Comments:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: